Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma.
about
Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentaryPilot study of dacetuzumab in combination with rituximab and gemcitabine for relapsed or refractory diffuse large B-cell lymphoma.Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma.Rituximab, Gemcitabine, Cisplatin and Methylprednisolone (R-GEM-P) is an effective regimen in relapsed diffuse large B-cell lymphoma.Efficacy and toxicity of PACEBOM chemotherapy in relapsed/refractory aggressive lymphoma in the rituximab era.Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathyRituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trialUnresolved issues in diffuse large B-cell lymphomas.Gemox: a widely useful therapy against solid tumors-review and personal experience.Pixantrone-rituximab versus gemcitabine-rituximab in relapsed/refractory aggressive non-Hodgkin lymphoma.Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma.Novel therapies for aggressive B-cell lymphomaA salvage chemotherapy of R-P-IMVP16/CBDCA consisting of rituximab, methylprednisolone, ifosfamide, methotrexate, etoposide, and carboplatin for patients with diffuse large B cell lymphoma who had previously received R-CHOP therapy as first-line cheSafety and efficacy of rituximab plus bendamustine in relapsed or refractory diffuse large B-cell lymphoma patients: an Italian retrospective multicenter study.Outcome for patients with relapsed/refractory aggressive lymphoma treated with gemcitabine and oxaliplatin with or without rituximab; a retrospective, multicentre study.Biweekly dose-dense gemcitabine-oxaliplatin and dexamethasone for relapsed/refractory aggressive non-Hodgkin lymphoma: A multicenter, single-arm, phase II trial.The Use of Anti-CD40 mAb in Cancer.Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group
P2860
Q28088365-76E793F6-AA92-4DCF-B287-3DA108A3FEEAQ33402203-FFABEF50-CE43-4EA8-A31A-2847AA076106Q33409872-6C109F24-C3B3-496F-BC6D-4F0CFCABEEDFQ33416550-7A2A0C07-9160-4D16-A16F-CB0E1258EB06Q33437806-E43FEF26-C07C-4029-9F38-DED1BA43CCB1Q35673260-77451D57-588E-4172-A030-9057520E33A8Q37273186-D216FA4B-1F79-44E7-AA14-DD3BFA41A621Q37705417-FD9DEFF1-78B5-4AB3-8893-4B456EA20046Q37814700-D1E35ABD-21A5-462D-A660-3338F7BE734EQ38878964-409F87F4-E60D-41B6-9AB3-6E8AF2FE42ADQ40163155-EB8503D9-CAD7-4F21-B655-3ABD7C51E3A4Q42011578-C0150C96-92A2-449E-80F4-D3EC0FD0AC0EQ50247640-92EF5840-40D0-414F-9E59-454591D2C141Q52895479-43537DC5-5B05-4E03-8690-BA31646F4832Q52955130-33525957-9460-492E-98B0-1FAA6B7334E3Q53153689-9C2C6793-877E-486F-8643-EB29EFBB1C54Q53321210-2332A536-82F3-404A-9745-B644A5E0B9A6Q58801965-A3B98F86-FED9-426D-A5A9-7EC01B72FEA2
P2860
Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Long-term results of gemcitabi ...... ory/relapsing B-cell lymphoma.
@ast
Long-term results of gemcitabi ...... ory/relapsing B-cell lymphoma.
@en
type
label
Long-term results of gemcitabi ...... ory/relapsing B-cell lymphoma.
@ast
Long-term results of gemcitabi ...... ory/relapsing B-cell lymphoma.
@en
prefLabel
Long-term results of gemcitabi ...... ory/relapsing B-cell lymphoma.
@ast
Long-term results of gemcitabi ...... ory/relapsing B-cell lymphoma.
@en
P2093
P1476
Long-term results of gemcitabi ...... ory/relapsing B-cell lymphoma.
@en
P2093
Annarosaria De Chiara
Antonio Pinto
Cristina Becchimanzi
Emilio Iannitto
Ferdinando Frigeri
Filippo Russo
Gaetana Capobianco
Gaetano Corazzelli
Gianpaolo Marcacci
Manuela Arcamone
P2888
P304
P356
10.1007/S00280-009-0941-9
P577
2009-02-15T00:00:00Z
P5875
P6179
1026151695